Oral surgery, oral medicine, oral pathology and oral radiology · 2026
Severe hemorrhage following maxillary osteotomies: frequency, predictors, and economic impact in the United States.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Han Michael D, Ahn Gloria, Vogel Sofie, Lee Min Kyeong, Allareddy Trishul V, Yadav Sumit, Allareddy Veerasathpurush
Аннотация
OBJECTIVES: To estimate the frequency of severe hemorrhage after maxillary osteotomies (HMx) and to identify their predictors and their economic impact.
STUDY DESIGN: Retrospective cohort study using the 2020-2022 National Inpatient Sample database, of encounters related to maxillary osteotomies.
METHODS: Outcome variables were HMx, hospital length of stay (LOS) and charges (HC). Predictor variables were surgical indication (obstructive sleep apnea, OSA vs non-OSA), socio-demographic factors, and comorbidities. Multivariable regression models were used to identify predictors of HMx, LOS, and HC (α=0.05).
RESULTS: Weighted frequency of HMx was 0.6%. Predictors of HMx were OSA (odds ratio [OR] 7.92), black race (OR 6.04), and drug abuse (OR 26.41). HMx was also associated with increased LOS (+6.26 days) and HC (+$109,187).
CONCLUSIONS: HMx are rare but have consequential impact on LOS and HC. Knowledge of the predictors can strengthen risk stratification to minimize adverse downstream effects related to this complication.
STUDY DESIGN: Retrospective cohort study using the 2020-2022 National Inpatient Sample database, of encounters related to maxillary osteotomies.
METHODS: Outcome variables were HMx, hospital length of stay (LOS) and charges (HC). Predictor variables were surgical indication (obstructive sleep apnea, OSA vs non-OSA), socio-demographic factors, and comorbidities. Multivariable regression models were used to identify predictors of HMx, LOS, and HC (α=0.05).
RESULTS: Weighted frequency of HMx was 0.6%. Predictors of HMx were OSA (odds ratio [OR] 7.92), black race (OR 6.04), and drug abuse (OR 26.41). HMx was also associated with increased LOS (+6.26 days) and HC (+$109,187).
CONCLUSIONS: HMx are rare but have consequential impact on LOS and HC. Knowledge of the predictors can strengthen risk stratification to minimize adverse downstream effects related to this complication.